Didactic Webinar Series
The ACTRIMS Didactic Webinar Series is offered nationally to neuroimmunology and MS fellows. An expert lecturer will present on niche topics to increase the educational yield for trainees. This series provides a forum for trainees to engage with advanced faculty on a scheduled basis.
Goals
- To use a virtual platform to provide national didactics on high-yield niche topics in neuroimmunology
- To increase comfort levels among neuro-immunology trainees on high-yield niche topics in neuroimmunology
- To provide fellows with the opportunity for direct interactions with topic experts
- To facilitate discussion and networking among MS/Neuroimmunology trainees
Learning Objectives
- Describe the tools underlying MS/Neuroimmunology evidence-based-practice, including trial design, lab-based testing and imaging.
- Compare the pathogenic mechanisms underlying MS and other neuroimmunologic diseases.
- Distinguish rare neuroimmune diseases and their mimics.
- Describe the issues affecting special populations (pediatric and advanced MS) and explain management strategies for these groups.
- Integrate cross-disciplinary tools to manage symptomatic concerns for MS and other neuroimmune diseases.
CE Accreditation This webinar series has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Interstate Postgraduate Medical Association (IPMA) and ACTRIMS. Interstate Postgraduate Medical Association designations this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. A survey will be sent to all participants after each webinar to claim credit for that specific webinar. If you are unable to watch the live webinars, you may watch them on-demand and still receive a CME certificate.
Registration If you are a neuroimmunology and/or MS fellow, register here. Contact Keri Lore with questions.
2023 - 2024 Calendar
Webinars will be scheduled tentatively on the dates below. A complete schedule with topics and speakers will be available soon.
ACTRIMS Didactic Webinar Series 2023-2024 |
September 22, 2023 |
Autoimmune Myelitis and Its Mimics Eoin Flanagan, Mayo Clinic |
October 6, 2023 |
Progressive MS: What It Is and What Can We Do About It? Robert Fox, Cleveland Clinic |
ECTRIMS Annual Congress - October 11-13, 2023 |
October 20, 2023 |
Principles of Immune Regulation and Immune Neural Interaction Amit Bar-Or, University of Pennsylvania |
November 3, 2023 |
Pediatric MS Brenda Banwell, Children's Hospital of Philadelphia |
November 17, 2023 |
MOGAD Erin Longbrake, Yale University |
December 1, 2023 |
Reproductive Health and Autoimmune CNS Disease Riley Bove, University of California - San Francisco |
December 15, 2023 |
Autoimmune Encephalitis Divyanshu (Div) Dubey, Mayo Clinic |
New Year - January 1, 2024 |
January 5, 2024 |
Antibody Mediated Pathogenesis in Multiple Sclerosis Jeffrey Bennett, University of Colorado |
January 19, 2024 |
Is It Optic Neuritis or Not? Steven Galetta, NYU Lagone |
February 2, 2024 |
Neurosarcoidosis Jeffrey Gelfand, University of California - San Francisco |
February 16, 2024 |
Microglia and Macrophages in MS Mariko Bennett, University of Pennsylvania |
ACTRIMS Forum 2024 - February 29-March 2, 2023 |
March 8, 2024 |
TBD |
March 15, 2024 |
Emerging Therapeutics in MS Jeffrey Cohen, Cleveland Clinic |
March 29, 2024 |
Neuropsychiatric Lupus and Neuro-Rheumatology Andrew Romeo, University of Michigan |
April 5, 2024 |
Neurological Complications of Cancer Immunotherapy and Paraneoplastic Diseases Sarah Flanagan Wesley, Columbia University |
AAN Annual Meeting - April 13-18, 2024 |
April 26, 2024 |
Differential Diagnosis for Inflammatory WM Disease in Children Sona Narula, Children's Hospital of Philadelphia |
May 10, 2024 |
Leukodystrophies Jennifer Orthmann-Murphy, University of Pennsylvania |
May 24, 2024 |
Lab Techniques & Tools for Understanding Antibody-Mediated Disease Andrew McKeon, Mayo Clinic |
June 7, 2024 |
TBD |
June 14, 2024 |
TBD |
|